Look for the Latest IBS-C Med, Tenapanor (Ibsrela)

June 2022

New Rx tenapanor (Ibsrela) for adults with irritable bowel syndrome with constipation (IBS-C) may show up on home med lists.

Tenapanor is the first "NHE3 (sodium/hydrogen exchanger 3) inhibitor" for IBS-C.

It's touted to have a "triple action" that blocks dietary sodium absorption...improves leaky gut...and reduces visceral hypersensitivity, or pain-sensing nerve activity in the GI tract.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Safety Improve Safe Use of Neuromuscular Blocking Agents
Transitions of Care Incorporate Discharge Med Rec Into Your Practice
Surgery Compare Zynrelef to Other Local Anesthetics
Cancer Help Overcome Barriers to Opioid Use for Cancer Pain
Aspirin Clear Up Confusion About Aspirin for CV Primary Prevention
Heart Failure Clarify New Heart Failure Terms and Management
Insomnia Watch for Daridorexant, a New Orexin Antagonist for Insomnia
Med Safety Be Aware of Rare PDE5 Inhibitor Risks
IBS Look for the Latest IBS-C Med, Tenapanor (Ibsrela)
Med Safety Keep Injectable Dyes Straight

Look for the Latest IBS-C Med, Tenapanor (Ibsrela)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents